| Brian Patrick Davis, MD | |
|
4740 Pearl Pkwy Ste 200, Boulder, CO 80301-3080 | |
| (303) 449-2730 | |
| Not Available |
| Full Name | Brian Patrick Davis |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery - Sports Medicine |
| Location | 4740 Pearl Pkwy Ste 200, Boulder, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124473194 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | BP10056453 (Texas) | Secondary |
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | DR.0065919 (Colorado) | Primary |
| Entity Name | Bouldercentre For Orthopedics Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336197631 PECOS PAC ID: 3971409020 Enrollment ID: O20031209000994 |
News Archive
UCLA investigators have identified a new molecule that may help regulate the delivery of fats to cells for energy and storage.
Nurses who care for patients with dementia now have a tailored approach to dental hygiene for their charges, thanks to a pilot study by a team of nurses.
Sigma-Aldrich® today announced that it has entered into an agreement with Pfizer under which Sigma-Aldrich will sell approximately 100 Pfizer-developed small molecule compounds to life science researchers for target characterization, assay development, screening and in vivo animal model applications.
XENTION LTD, the Cambridge-based biopharmaceutical company specialising in the discovery and development of ion channel-modulating drugs, reported positive data today from a phase 1 trial of XEN-D0103 administered orally.
The Wall Street Journal examines efforts to fight tuberculosis (TB) in Europe, writing, "All along the edges of Western Europe, new and hard-to-defeat strains of tuberculosis are gaining a foothold, often moving beyond traditional victims - alcoholics, drug users, HIV patients - and into the wider population."
› Verified 8 days ago
| Entity Name | Yuma District Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841343407 PECOS PAC ID: 6305758830 Enrollment ID: O20031223000344 |
News Archive
UCLA investigators have identified a new molecule that may help regulate the delivery of fats to cells for energy and storage.
Nurses who care for patients with dementia now have a tailored approach to dental hygiene for their charges, thanks to a pilot study by a team of nurses.
Sigma-Aldrich® today announced that it has entered into an agreement with Pfizer under which Sigma-Aldrich will sell approximately 100 Pfizer-developed small molecule compounds to life science researchers for target characterization, assay development, screening and in vivo animal model applications.
XENTION LTD, the Cambridge-based biopharmaceutical company specialising in the discovery and development of ion channel-modulating drugs, reported positive data today from a phase 1 trial of XEN-D0103 administered orally.
The Wall Street Journal examines efforts to fight tuberculosis (TB) in Europe, writing, "All along the edges of Western Europe, new and hard-to-defeat strains of tuberculosis are gaining a foothold, often moving beyond traditional victims - alcoholics, drug users, HIV patients - and into the wider population."
› Verified 8 days ago
| Entity Name | Wray Community District Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477587202 PECOS PAC ID: 3274425038 Enrollment ID: O20040326000383 |
News Archive
UCLA investigators have identified a new molecule that may help regulate the delivery of fats to cells for energy and storage.
Nurses who care for patients with dementia now have a tailored approach to dental hygiene for their charges, thanks to a pilot study by a team of nurses.
Sigma-Aldrich® today announced that it has entered into an agreement with Pfizer under which Sigma-Aldrich will sell approximately 100 Pfizer-developed small molecule compounds to life science researchers for target characterization, assay development, screening and in vivo animal model applications.
XENTION LTD, the Cambridge-based biopharmaceutical company specialising in the discovery and development of ion channel-modulating drugs, reported positive data today from a phase 1 trial of XEN-D0103 administered orally.
The Wall Street Journal examines efforts to fight tuberculosis (TB) in Europe, writing, "All along the edges of Western Europe, new and hard-to-defeat strains of tuberculosis are gaining a foothold, often moving beyond traditional victims - alcoholics, drug users, HIV patients - and into the wider population."
› Verified 8 days ago
| Entity Name | East Phillips County Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891733879 PECOS PAC ID: 9638161615 Enrollment ID: O20040331000584 |
News Archive
UCLA investigators have identified a new molecule that may help regulate the delivery of fats to cells for energy and storage.
Nurses who care for patients with dementia now have a tailored approach to dental hygiene for their charges, thanks to a pilot study by a team of nurses.
Sigma-Aldrich® today announced that it has entered into an agreement with Pfizer under which Sigma-Aldrich will sell approximately 100 Pfizer-developed small molecule compounds to life science researchers for target characterization, assay development, screening and in vivo animal model applications.
XENTION LTD, the Cambridge-based biopharmaceutical company specialising in the discovery and development of ion channel-modulating drugs, reported positive data today from a phase 1 trial of XEN-D0103 administered orally.
The Wall Street Journal examines efforts to fight tuberculosis (TB) in Europe, writing, "All along the edges of Western Europe, new and hard-to-defeat strains of tuberculosis are gaining a foothold, often moving beyond traditional victims - alcoholics, drug users, HIV patients - and into the wider population."
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brian Patrick Davis, MD Po Box 110429, Aurora, CO 80042-0429 Ph: () - | Brian Patrick Davis, MD 4740 Pearl Pkwy Ste 200, Boulder, CO 80301-3080 Ph: (303) 449-2730 |
News Archive
UCLA investigators have identified a new molecule that may help regulate the delivery of fats to cells for energy and storage.
Nurses who care for patients with dementia now have a tailored approach to dental hygiene for their charges, thanks to a pilot study by a team of nurses.
Sigma-Aldrich® today announced that it has entered into an agreement with Pfizer under which Sigma-Aldrich will sell approximately 100 Pfizer-developed small molecule compounds to life science researchers for target characterization, assay development, screening and in vivo animal model applications.
XENTION LTD, the Cambridge-based biopharmaceutical company specialising in the discovery and development of ion channel-modulating drugs, reported positive data today from a phase 1 trial of XEN-D0103 administered orally.
The Wall Street Journal examines efforts to fight tuberculosis (TB) in Europe, writing, "All along the edges of Western Europe, new and hard-to-defeat strains of tuberculosis are gaining a foothold, often moving beyond traditional victims - alcoholics, drug users, HIV patients - and into the wider population."
› Verified 8 days ago
Jennah Mann, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2150 Stadium Dr 2nd Floor, Boulder, CO 80309 Phone: 720-848-0000 | |
William C. Kramer, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4740 Pearl Pkwy Ste 200, Boulder, CO 80301 Phone: 303-449-2730 Fax: 303-449-5821 | |
Dr. Stephen D Paul, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4740 Pearl Pkwy Ste 200, Boulder, CO 80301 Phone: 303-449-2730 Fax: 303-449-2730 | |
Dr. James B Rector, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4740 Pearl Pkwy Ste 200, Boulder, CO 80301 Phone: 303-449-2790 Fax: 303-449-5821 | |
Robert A Harper, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4740 Pearl Pkwy Ste 200, Boulder, CO 80301 Phone: 303-449-2730 | |
Dirk Dolbeare, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4740 Pearl Pkwy Ste 200, Boulder, CO 80301 Phone: 303-449-2730 Fax: 303-449-5821 |